Celcuity Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: CELC · Form: 8-K · Filed: May 30, 2024 · CIK: 1603454
Sentiment: neutral
Topics: material-agreement, debt-obligation, equity-sale
TL;DR
Celcuity inked a deal, took on debt, and sold shares. Details TBD.
AI Summary
Celcuity Inc. announced on May 30, 2024, that it entered into a material definitive agreement. The company also disclosed the creation of a direct financial obligation and unregistered sales of equity securities. Specific details regarding the agreement, financial obligations, and equity sales were not provided in this initial filing.
Why It Matters
This filing indicates significant corporate activity, including a new agreement and potential dilution from equity sales, which could impact the company's financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement, direct financial obligations, and unregistered equity sales, all of which can introduce financial and operational risks.
Key Players & Entities
- Celcuity Inc. (company) — Registrant
- May 30, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Celcuity Inc.?
The filing states that Celcuity Inc. entered into a material definitive agreement on May 30, 2024, but does not provide specific details about the agreement itself.
What type of direct financial obligation has Celcuity Inc. created?
The 8-K filing indicates the creation of a direct financial obligation by Celcuity Inc., but the specific terms and nature of this obligation are not detailed in the provided text.
Were there any unregistered sales of equity securities by Celcuity Inc.?
Yes, the filing explicitly lists 'Unregistered Sales of Equity Securities' as an item of disclosure for Celcuity Inc. on May 30, 2024.
What is the primary business of Celcuity Inc.?
Celcuity Inc. is classified under 'SERVICES-MEDICAL LABORATORIES [8071]' according to its SIC code.
When was Celcuity Inc. incorporated and in which state?
Celcuity Inc. was incorporated in Delaware.
Filing Stats: 1,746 words · 7 min read · ~6 pages · Grade level 11.6 · Accepted 2024-05-30 07:05:23
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share CELC The Nasdaq
- $180 million — the aggregate principal amount of up to $180 million. The A&R Loan Agreement amends and rest
- $100 million — oan Agreement"). Funding of the first $100 million under the A&R Loan Agreement will occur
- $16.8 million — 30, 2024, including tranche payments of $16.8 million (the "Term A Loan") and $21.5 million (
- $21.5 million — f $16.8 million (the "Term A Loan") and $21.5 million (the "Term B Loan") reflecting repaymen
- $61.7 million — ayment-in-kind interest, in addition to $61.7 million of new borrowings (the "Term C Loan").
- $30.0 million — eligible to draw on a fourth tranche of $30.0 million (the "Term D Loan") and fifth tranche o
- $50 million — the "Term D Loan") and fifth tranche of $50 million (the "Term E Loan"), in each case upon
- $45 million — additional term loans to the Company of $45 million (the "Term F Loan"). Funding of these a
- $10.00 — 's common stock at a price per share of $10.00 (the "Conversion Right"). Innovatus wil
- $14.40 — of common stock at a price per share of $14.40 through April 8, 2031. In connection
Filing Documents
- form8-k.htm (8-K) — 53KB
- ex4-1.htm (EX-4.1) — 96KB
- ex10-1.htm (EX-10.1) — 442KB
- ex99-1.htm (EX-99.1) — 26KB
- ex99-1_001.jpg (GRAPHIC) — 29KB
- 0001493152-24-021864.txt ( ) — 939KB
- celc-20240530.xsd (EX-101.SCH) — 3KB
- celc-20240530_lab.xml (EX-101.LAB) — 34KB
- celc-20240530_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 30, 2024 CELCUITY INC. By /s/ Brian F. Sullivan Brian F. Sullivan Chief Executive Officer 4